Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Afatinib often causes skin problems that need proactive management.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Baricitinib is effective as a treatment for severe hair loss.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Sorafenib can cause a unique skin reaction.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Tofacitinib might be used to treat hair loss.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Erlotinib can cause hair loss as a side effect.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

A woman's hair turned white after taking a cancer drug called dasatinib.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

New treatments for a type of skin cancer show promise but have side effects and may work better with other therapies.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.